Eli Lilly’s weak fourth-quarter sales cloud 2023 profit forecast
(Reuters) – Eli Lilly and Co forecast full-year profit above Wall Street estimates on Thursday, banking on rising demand for its new diabetes drug Mounjaro to offset pressure from waning sales of some of its older treatments.